Exporter

EN
FR
Coagulation factor VIII
Statut de médicament essentiel
Description générale
Factor VIII also known as anti-hemophilic A factor is used to treat and prevent bleeding in people with hemophilia A and other causes of factor VIII deficiency.
Codes ATC
Type de médicament
Biological agent
Historique des statuts LME
Ajouté pour la première fois en 1979 (TRS 641) pour Haemophilia A
Recommandations
Section
Blood coagulation factors
  • Parenteral > General injections > IV: 250 IU in vial powder for injection; 500 IU in vial powder for injection; 1000 IU in vial powder for injection
Indications